Clinical Trial Update: Early Feasibility Study of the CardiAQ™ TMVI System (Transfemoral and Transapical DS) [NA]

View source ↗

Summary

An early feasibility study of Edwards Lifesciences' CardiAQ transcatheter mitral valve implantation system (transfemoral and transapical) has been withdrawn. Th…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cardiovascular Disease
• Heart Disease
• Heart Valve Disease
• Mitral Valve Insufficiency

Snippet

Sponsor: Edwards Lifesciences | Conditions: Mitral Insufficiency, Heart Valve Disease | NA | Status: WITHDRAWN